The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
Nadine Rouphael,Michele Paine,Regina Mosley,Sébastien Henry,Devin V. McAllister,Haripriya Kalluri,Winston Pewin,Paula M. Frew,Tianwei Yu,Natalie J. Thornburg,Sarah Kabbani,Lilin Lai,Elena V. Vassilieva,Ioanna Skountzou,Richard W. Compans,Mark J. Mulligan,Mark R. Prausnitz,Allison Beck,Srilatha Edupuganti,Sheila Heeke